Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2000 1
2007 1
2011 1
2012 1
2013 3
2014 1
2016 3
2017 1
2018 1
2019 6
2020 2
2021 3
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Management of toxicities of immune checkpoint inhibitors.
Spain L, Diem S, Larkin J. Spain L, et al. Cancer Treat Rev. 2016 Mar;44:51-60. doi: 10.1016/j.ctrv.2016.02.001. Epub 2016 Feb 6. Cancer Treat Rev. 2016. PMID: 26874776 Review.
Immune checkpoint inhibition with the anti-CTLA-4 antibody ipilimumab and the anti-PD-1 antibodies nivolumab and pembrolizumab has improved survival in metastatic melanoma, lung cancer and renal cancer. Use of these agents holds promise in other malignancies. ...Thi …
Immune checkpoint inhibition with the anti-CTLA-4 antibody ipilimumab and the anti-PD-1 antibodies nivolumab and pembrolizumab has improved …
Dynamic Treatment Stratification Using ctDNA.
Vidal J, Taus A, Montagut C. Vidal J, et al. Recent Results Cancer Res. 2020;215:263-273. doi: 10.1007/978-3-030-26439-0_14. Recent Results Cancer Res. 2020. PMID: 31605234 Review.
Liquid biopsy clinical applications include molecular diagnosis, determination of tumor load as a surrogate marker of early response, monitoring of mutations of resistance to targeted therapy and detection of minimal residual disease after cancer surgery. ...Special emphas …
Liquid biopsy clinical applications include molecular diagnosis, determination of tumor load as a surrogate marker of early response, monito …
Targeted Treatment of Brain Metastases.
Shonka N, Venur VA, Ahluwalia MS. Shonka N, et al. Curr Neurol Neurosci Rep. 2017 Apr;17(4):37. doi: 10.1007/s11910-017-0741-2. Curr Neurol Neurosci Rep. 2017. PMID: 28326470 Review.
Historically, the median survival after the diagnosis of brain metastases has been dismal and medical therapies had a limited role in the management of these patients. RECENT FINDINGS: The advent of targeted therapy has ushered in an era of increased hope for patien …
Historically, the median survival after the diagnosis of brain metastases has been dismal and medical therapies had a limited role in …
Application of Immune Checkpoint Inhibitors in the Treatment of Cholangiocarcinoma.
Zeng FL, Chen JF. Zeng FL, et al. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211039952. doi: 10.1177/15330338211039952. Technol Cancer Res Treat. 2021. PMID: 34528830 Free PMC article. Review.
Progressive cholangiocarcinoma yields poor outcomes with radiotherapy; therefore, there is an urgent need for new therapeutic breakthroughs. Immune checkpoint inhibitor (ICI) therapy brings the treatment for cancer into a new field, with the use of drugs targeting P …
Progressive cholangiocarcinoma yields poor outcomes with radiotherapy; therefore, there is an urgent need for new therapeutic breakth …
Novel Immunotherapeutics for Treatment of Glioblastoma: The Last Decade of Research.
Khansur E, Shah AH, Lacy K, Komotar RJ. Khansur E, et al. Cancer Invest. 2019;37(1):1-7. doi: 10.1080/07357907.2018.1479414. Epub 2019 Jan 11. Cancer Invest. 2019. PMID: 30632816 Review.
Because of the dismal prognosis, attention has shifted to alternative adjuvant treatment modalities. Although traditionally limited to systemic malignancies (melanoma, lung and colon cancer), the field of immunotherapy has recently identified glioblastoma as a poten …
Because of the dismal prognosis, attention has shifted to alternative adjuvant treatment modalities. Although traditionally limited to syste …
A multidisciplinary consensus on the morphological and functional responses to immunotherapy treatment.
Leon-Mateos L, Garcia-Velloso MJ, García-Figueiras R, Rodriguez-Moreno JF, Vercher-Conejero JL, Sánchez M, Perez Gracia JL, Simo-Perdigo M, Gorospe L. Leon-Mateos L, et al. Clin Transl Oncol. 2021 Mar;23(3):434-449. doi: 10.1007/s12094-020-02442-3. Epub 2020 Jul 4. Clin Transl Oncol. 2021. PMID: 32623581 Free PMC article.
Currently, immunotherapy is indicated in the treatment of patients with head and neck tumors, melanoma, lung cancer, bladder tumors, colon cancer, cervical cancer, breast cancer, Merkel cell carcinoma, liver cancer, leukemia and lymphomas. ...
Currently, immunotherapy is indicated in the treatment of patients with head and neck tumors, melanoma, lung cancer, bladder t …
Management of Brain Metastases in the New Era of Checkpoint Inhibition.
Lauko A, Thapa B, Venur VA, Ahluwalia MS. Lauko A, et al. Curr Neurol Neurosci Rep. 2018 Aug 18;18(10):70. doi: 10.1007/s11910-018-0877-8. Curr Neurol Neurosci Rep. 2018. PMID: 30121715 Review.
PURPOSE OF THE REVIEW: Brain metastasis is a common complication of advanced malignancies, especially, lung cancer, breast cancer, renal cell carcinoma, and melanoma. Traditionally surgery, when indicated, and radiation therapy, either as whole-brain radiatio …
PURPOSE OF THE REVIEW: Brain metastasis is a common complication of advanced malignancies, especially, lung cancer, breast cancer, re …
Adenosine Receptors as Novel Targets for the Treatment of Various Cancers.
Gorain B, Choudhury H, Yee GS, Bhattamisra SK. Gorain B, et al. Curr Pharm Des. 2019;25(26):2828-2841. doi: 10.2174/1381612825666190716102037. Curr Pharm Des. 2019. PMID: 31333092 Review.
The first category of AR, A1 is known to play an antitumour activity via tumour-associated microglial cells to prevent the development of glioblastomas. A2AAR are found in melanoma, lung, and breast cancer cells, where tumour proliferation is stimulated due to inhib …
The first category of AR, A1 is known to play an antitumour activity via tumour-associated microglial cells to prevent the development of gl …
Management of isolated adrenal metastases.
Shumarova SY. Shumarova SY. Khirurgiia (Sofiia). 2016;82(2):87-96. Khirurgiia (Sofiia). 2016. PMID: 29667389 Review.
The most common primary malignant disorders metastasizing into the adrenal glands are renal-cell carcinoma, melanoma, lung carcinoma, and colorectal carcinomas [8, 10-12]. The abundant sinusoidal blood supply of the adrenal glands and the possible communication betw …
The most common primary malignant disorders metastasizing into the adrenal glands are renal-cell carcinoma, melanoma, lung car …
Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management.
Allemailem KS, Alsahli MA, Almatroudi A, Alrumaihi F, Al Abdulmonem W, Moawad AA, Alwanian WM, Almansour NM, Rahmani AH, Khan AA. Allemailem KS, et al. Int J Nanomedicine. 2023 Sep 29;18:5531-5559. doi: 10.2147/IJN.S424872. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37795042 Free PMC article. Review.
The manipulation of immunogenetic regulators has opened a new interface for designing, implementation and interpretation of CRISPR/Cas9-based screening in immuno-oncology. Several cancers like lymphoma, melanoma, lung, and liver malignancies have been treated with t …
The manipulation of immunogenetic regulators has opened a new interface for designing, implementation and interpretation of CRISPR/Cas9-base …
27 results